MAA
TMO icon

Matrix Asset Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Matrix Asset Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
27,668
+5,121
+23% +$2.46M 1.13% 36
2026
Q1 		$11.1M Buy
22,547
+1,206
+6% +$654K 1.02% 37
2025
Q4 		$12.4M Sell
21,341
-170
-0.8% -$96.1K 1.11% 36
2025
Q3 		$10.4M Buy
21,511
+134
+0.6% +$62.4K 0.97% 41
2025
Q2 		$8.67M Buy
21,377
+5,665
+36% +$2.37M 0.88% 42
2025
Q1 		$7.82M Sell
15,712
-3,744
-19% -$2.03M 0.86% 42
2024
Q4 		$10.1M Sell
19,456
-297
-2% -$163K 1.11% 32
2024
Q3 		$12.2M Sell
19,753
-436
-2% -$258K 1.36% 32
2024
Q2 		$11.2M Sell
20,189
-822
-4% -$471K 1.33% 32
2024
Q1 		$12.2M Sell
21,011
-956
-4% -$536K 1.46% 33
2023
Q4 		$11.7M Sell
21,967
-267
-1% -$129K 1.48% 31
2023
Q3 		$11.3M Buy
22,234
+39
+0.2% +$20.8K 1.6% 26
2023
Q2 		$11.6M Buy
22,195
+27
+0.1% +$14.6K 1.6% 28
2023
Q1 		$12.8M Sell
22,168
-6
-0% -$3.38K 1.85% 22
2022
Q4 		$12.2M Sell
22,174
-176
-0.8% -$93.3K 1.83% 19
2022
Q3 		$11.3M Sell
22,350
-129
-0.6% -$72.2K 1.86% 23
2022
Q2 		$12.2M Sell
22,479
-17
-0.1% -$9.36K 1.88% 21
2022
Q1 		$13.3M Buy
22,496
+634
+3% +$364K 1.79% 24
2021
Q4 		$14.6M Sell
21,862
-202
-0.9% -$126K 1.9% 20
2021
Q3 		$12.6M Buy
22,064
+2
+0% +$1.1K 1.77% 26
2021
Q2 		$11.1M Buy
22,062
+233
+1% +$110K 1.6% 30
2021
Q1 		$9.96M Sell
21,829
-11
-0.1% -$5.25K 1.49% 30
2020
Q4 		$10.2M Sell
21,840
-2,194
-9% -$1.03M 1.72% 24
2020
Q3 		$10.6M Sell
24,034
-544
-2% -$225K 2.06% 17
2020
Q2 		$8.91M Sell
24,578
-8,163
-25% -$2.74M 1.71% 27
2020
Q1 		$9.29M Sell
32,741
-5,614
-15% -$1.77M 2.11% 15
2019
Q4 		$12.5M Sell
38,355
-2,160
-5% -$655K 2.03% 16
2019
Q3 		$11.8M Sell
40,515
-1,011
-2% -$290K 2.09% 15
2019
Q2 		$12.2M Sell
41,526
-6,431
-13% -$1.77M 2.16% 14
2019
Q1 		$13.1M Sell
47,957
-2,023
-4% -$503K 2.24% 16
2018
Q4 		$11.2M Sell
49,980
-2,949
-6% -$692K 2.08% 16
2018
Q3 		$12.9M Sell
52,929
-7,502
-12% -$1.73M 2.06% 19
2018
Q2 		$12.5M Sell
60,431
-2,159
-3% -$458K 2.07% 19
2018
Q1 		$12.9M Sell
62,590
-2,050
-3% -$430K 2.13% 18
2017
Q4 		$12.3M Sell
64,640
-2,428
-4% -$465K 1.95% 21
2017
Q3 		$12.7M Sell
67,068
-1,505
-2% -$273K 2.09% 20
2017
Q2 		$12M Sell
68,573
-1,524
-2% -$256K 2.05% 22
2017
Q1 		$10.8M Sell
70,097
-3,545
-5% -$542K 1.89% 24
2016
Q4 		$10.4M Buy
73,642
+1,892
+3% +$279K 1.76% 25
2016
Q3 		$11.4M Sell
71,750
-4,807
-6% -$741K 2.01% 24
2016
Q2 		$11.3M Sell
76,557
-3,763
-5% -$555K 2.2% 19
2016
Q1 		$11.4M Sell
80,320
-4,214
-5% -$565K 2.24% 20
2015
Q4 		$12M Sell
84,534
-47,273
-36% -$6.31M 2.31% 20
2015
Q3 		$16.1M Sell
131,807
-3,995
-3% -$520K 2.3% 23
2015
Q2 		$17.6M Sell
135,802
-33,135
-20% -$4.32M 2.21% 28
2015
Q1 		$22.7M Sell
168,937
-2,792
-2% -$360K 2.62% 19
2014
Q4 		$21.5M Sell
171,729
-606
-0.4% -$73.7K 2.43% 22
2014
Q3 		$21M Sell
172,335
-532
-0.3% -$64.7K 2.44% 22
2014
Q2 		$20.4M Sell
172,867
-870
-0.5% -$102K 2.32% 25
2014
Q1 		$20.9M Sell
173,737
-6,520
-4% -$775K 2.5% 22
2013
Q4 		$20.1M Sell
180,257
-2,706
-1% -$269K 2.44% 21
2013
Q3 		$16.9M Sell
182,963
-3,324
-2% -$301K 2.27% 23
2013
Q2 		$15.8M Buy
+186,287
New +$15.5M 2.2% 26

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Matrix Asset Advisors's TMO Position: Q2 2026 in Review

Matrix Asset Advisors increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $2.46M and bringing the position to 27,668 shares worth $13.9M. The position accounts for 1.13% of the portfolio, ranked #36.

Matrix Asset Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.7M in Q1 2015. 462 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Matrix Asset Advisors held 27,668 shares of Thermo Fisher Scientific worth $13.9M as of Q2 2026.
  • Matrix Asset Advisors bought 5,121 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.46M.
  • Thermo Fisher Scientific made up 1.13% of Matrix Asset Advisors's portfolio in Q2 2026, its #36 holding.
  • Matrix Asset Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Matrix Asset Advisors's Thermo Fisher Scientific position peaked at $22.7M in Q1 2015.
  • 462 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Matrix Asset Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.